Top Markets
#1 ADO Protocol ADO Protocol +329.37%
#2 GoPlus Security GoPlus Security +53.93%
#3 Verus Coin Verus Coin +43.47%
#4 Nockchain Nockchain +40.54%
#5 The Black Bull The Black Bull +39.50%
#6 Starpower Starpower +35.61%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +34.02%
#8 Tutorial Tutorial +27.75%
#9 Fake World Assets Fake World Assets +24.98%
#10 GAIB AID GAIB AID +24.67%
Coin of the day
ADO Protocol ADO Protocol
Innstillinger
Språk
NORSK
Valuta
USD
Tema
PhoenixBio Co., Ltd. PhoenixBio Co., Ltd.

PhoenixBio Co., Ltd.

6190
Rangering i aksjer #32813
PhoenixBio Co., Ltd. delivers specialized contract research services to support... PhoenixBio Co., Ltd. delivers specialized contract research services to support drug discovery and development, with a primary focus on the Japanese market. Central to its offerings is the proprietary PXB-mouse, a unique chimeric mouse model featuring a humanized liver, which is critical for various drug development experiments. The company also conducts in vitro analyses utilizing fresh human hepatocytes sourced from PXB-cells. This sophisticated humanized liver model proves invaluable for in vivo studies encompassing gene therapy, NASH/NAFLD drug development programs, anti-viral therapeutic evaluations, DMPK (Drug Metabolism and Pharmacokinetics) and toxicity assessments, and custom transplantation projects. Established in 2002, PhoenixBio maintains its headquarters in Higashihiroshima, Japan.
Aksjekurs
$2.22
Markedsverdi
$9.03M
Endring (1 dag)
-3.13%
Endring (1 år)
-21.92%
Land
JP
Handel PhoenixBio Co., Ltd. (6190)

Kategori

Healthcare
P/B-forhold for PhoenixBio Co., Ltd. (6190)
P/B-forhold per 2026 TTM: 0
Ifølge PhoenixBio Co., Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for PhoenixBio Co., Ltd. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE